Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Farmers Insurance
Covington
Moodys
Healthtrust
Medtronic
Baxter
McKinsey
Accenture
Cipla

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040636

« Back to Dashboard

NDA 040636 describes BETHANECHOL CHLORIDE, which is a drug marketed by Able, Actavis Elizabeth, Amneal Pharm, Ascot, Eci Pharms Llc, Heritage Pharma, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lannett Holdings Inc, Sandoz, Sun Pharm Inds Inc, Upsher-smith Labs, Watson Labs, and Wockhardt, and is included in forty-seven NDAs. It is available from eighteen suppliers. Additional details are available on the BETHANECHOL CHLORIDE profile page.

The generic ingredient in BETHANECHOL CHLORIDE is bethanechol chloride. There are eight drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
Summary for 040636
Tradename:BETHANECHOL CHLORIDE
Applicant:Upsher-smith Labs
Ingredient:bethanechol chloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 040636
Medical Subject Heading (MeSH) Categories for 040636
Suppliers and Packaging for NDA: 040636
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 040636 ANDA Upsher-Smith Laboratories, LLC 0832-0513 0832-0513-50 500 TABLET in 1 BOTTLE (0832-0513-50)
BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 040636 ANDA Upsher-Smith Laboratories, LLC 0832-0513 0832-0513-01 100 BLISTER PACK in 1 CARTON (0832-0513-01) > 1 TABLET in 1 BLISTER PACK (0832-0513-89)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Jun 1, 2005TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Healthtrust
McKinsey
Harvard Business School
QuintilesIMS
Julphar
Moodys
Medtronic
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot